Intravenous Magnesium Sulphate versus Esmolol for Attenuation of Hemodynamic Responses During Tracheal Extubation: A Prospective Randomized Comparative Study
International Journal of Drug Delivery Technology · 16.04.2026 · 16 (14s)
DOI: 10.25258/ijddt.16.14s.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.04.2026. Verfasst von Dr. Vinamra Tiwari und 1 weiteren Autor:innen.
Themen: Beatmung und Weaning
Abstract (Originalsprache)
Tracheal extubation is associated with significant sympathetic stimulation leading to tachycardia and hypertension. These hemodynamic responses may be harmful, particularly in patients with cardiovascular or cerebrovascular disease. Various pharmacological agents have been investigated to attenuate these responses, among which magnesium sulphate and esmolol have demonstrated promising results.
Aim
To compare the efficacy of intravenous magnesium sulphate and intravenous esmolol in attenuating hemodynamic responses during tracheal extubation in patients undergoing surgeries under general anaesthesia. Materials and Methods: This prospective randomized comparative study was conducted on 55 patients aged 18–60 years belonging to ASA physical status I and II undergoing elective surgeries under general anaesthesia. Patients were randomly divided into two groups: Group M (n=28) receiving intravenous magnesium sulphate and Group E (n=27) receiving intravenous esmolol prior to extubation. Hemodynamic parameters including heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) were recorded at baseline, at extubation, and at 1, 3, and 5 minutes after extubation. Statistical analysis was performed using appropriate tests with p < 0.05 considered significant.
Results
Both magnesium sulphate and esmolol attenuated the hemodynamic responses associated with tracheal extubation. However, the rise in heart rate and blood pressure was significantly lower in the magnesium sulphate group compared to the esmolol group at extubation and during the immediate post-extubation period (p < 0.05). The incidence of adverse effects was minimal in both groups, although bradycardia was more frequently observed in patients receiving esmolol.
Conclusion
Intravenous magnesium sulphate is more effective than intravenous esmolol in attenuating hemodynamic responses during tracheal extubation and provides better cardiovascular stability with minimal adverse effects.
Zitieren
APA
Tiwari, D. V., & Tripathi, D. S. (2026). Intravenous Magnesium Sulphate versus Esmolol for Attenuation of Hemodynamic Responses During Tracheal Extubation: A Prospective Randomized Comparative Study. International Journal of Drug Delivery Technology, 16(14s). https://doi.org/10.25258/ijddt.16.14s.13
Vancouver
Tiwari DV, Tripathi DS. Intravenous Magnesium Sulphate versus Esmolol for Attenuation of Hemodynamic Responses During Tracheal Extubation: A Prospective Randomized Comparative Study. International Journal of Drug Delivery Technology. 2026;16(14s). doi:10.25258/ijddt.16.14s.13
BibTeX
@article{Tiwari2026,
author = {Tiwari, Dr. Vinamra and Tripathi, Dr. Shruti},
title = {Intravenous Magnesium Sulphate versus Esmolol for Attenuation of Hemodynamic Responses During Tracheal Extubation: A Prospective Randomized Comparative Study},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {14s},
doi = {10.25258/ijddt.16.14s.13}
}
EUVIMED